Navigation Links
Prostate cancer screening program leads to bigger fall in death rates than surrounding areas
Date:4/22/2008

The expected number of deaths from prostate cancer more than halved in the Tyrol after a programme was introduced to improve early detection and treatment of the disease, according to research published in April issue of the urology journal BJU International.

Nearly 87 per cent of eligible men have been tested at least once since the programme was introduced in 1988. By 2005 cancer deaths had fallen by 54 per cent, compared with 29 per cent for the rest of Austria, which hadnt benefited from the programme.

There is no evidence that trends in the Tyrol and the rest of Austria were significantly different before free testing was introduced.

Prostate specific antigen (PSA) testing was introduced to the Tyrol in 1988 and since 1993 it has been freely available to all men aged from 45 to 75 and to men under 40 with a family history of the disease explains lead author Professor Georg Bartsch from the University of Innsbruck, one of the international team of medical experts that makes up the Tyrol Prostate Cancer Screening Group.

Our findings suggest that the combination of free PSA testing and free treatment for any resulting prostate cancer can lead to significant reductions in death rates. This free treatment normally involved surgical removal of the prostate.

What was interesting about this study was that so many men came forward for testing after the programme was widely advertised in the print and broadcast media. People living in the Tyrol one of the nine Federal states that make up Austria tend to enjoy close proximity to health facilities and be very receptive to preventative medical programmes.

By 2005, just under 87 per cent of men aged between 45 and 75 living in the region had undergone a PSA test.

Our study clearly shows that deaths from prostate cancer have declined much more quickly in the Tyrol since 1988, when this programme was introduced, compared with the rest of Austria.


'/>"/>
Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...Provides Online Resource and Fire Safety Tips for ... Boston, MA (PRWEB) December 2, 2008 --...ete , actress, philanthropist and mother of four, ...a few moments before the holiday rush to review fi...Smart.com. , , , , ,Home fires top the list of Am...
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
Breaking Medicine News(10 mins):Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...e city's health services panel Friday approved a p...fixed fine for anyone who breaches tough new anti-...rafted in to back up the teams of tobacco control ...ponsibility of enforcing the no-smoking policy. S...
... researchers have found evidence that tropical cyc... ocean circulation patterns that transport heat a...e. According to Matthew Huber, Purdue University ...ciences who led the research group, the findings s...
...Over one hundred Long Island AARP members gathered...n before the end of the 2007 Legislative Session i...ore affordable and help assure that their cell pho...heir message directly to their legislators during ...
...aken up a rather strange hobby to help her keep fi...ly revealed that she has taken to the trapeze to k...for your confidence and amazing for your body but ... do something that pushed me,' the Daily Express q...
Other Medicine News:Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
(Date:12/1/2008)...n has announced that an oral,presentation of pre...nical,trial of TG101348 in myeloproliferative dis...ican Society of Hematology (ASH) Meeting. , , ... Title: A Phase I Study of TG10134... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...-- Vical Incorporated (Nasdaq: VICL ) announced ...ent from Merck & Co., Inc. based on Merck,s pl... investigational plasmid DNA (pDNA) cancer vaccine...ne delivery technology and encodes human telomeras...ect of separate license agreement. , , "The...
(Date:11/27/2008)...phoblastic leukemia relapse cases arise from a cel..., MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswire...spital have identified distinctive genetic changes...blastic leukemia (ALL) that cause relapse. The fin...ALL relapse in children and, ultimately, in adults...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3American Society for Microbiology honors Vickie S Baselski 4075 1American Society for Microbiology honors Vickie S Baselski 4075 2American Society for Microbiology honors Vickie S Baselski 4075 3American Society for Microbiology honors Vickie S Baselski 4075 4The TPAA Names Mark Oelschlager President 6584 1The TPAA Names Mark Oelschlager President 6584 2Booster vaccination may help with possible future avian influenza pandemic 24115 1Booster vaccination may help with possible future avian influenza pandemic 24115 2Booster vaccination may help with possible future avian influenza pandemic 24115 3VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 1VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 2VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 3
...igestive Disease Week -, CAMBRIDGE, Mass., May 21,... presentation of data from a Phase 2 study in whic...oved bowel function,in patients with constipation-...se data also showed linaclotide was well tolerated...de is a first-in-class,compound currently being de...
...ay 21, 2007 - Medical,professionals seeking to tre...uired gram-negative pneumonia may have a new weapo... candidate being,developed by Nektar Therapeutics ...al evaluating the use of,NKTR-061 (Inhaled Amikaci...hospital-acquired gram-negative pneumonia were,pre...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
The 96-Well GeneAmp PCR System 9700 can now be used with Gold-plated Silver and Aluminum Sample Blocks Modules. The aluminum block has been designed for routine use of PCR reactions and cycle sequenc
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate
Ideal for day-to-day temperature cycling ,Unmatched well-to-well uniformity of 0.1C ,30% reduction in cycling time over Peltier or coolant-based cyclers ,4 programmable blocks eliminate tempera
...screen display which enables you to optimize your ...& Benefits include: Wide linear gradient, Touch S...alculator, Fold Control, High Performance, Versati...ment Software Upgrade. Includes a four year or 80...
Medicine Products: